These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5110261)

  • 1. [Study of the behavior of immunoglobulins in meningococcic infections].
    Chiodo F; Monari E; Pezzoli AM
    G Mal Infett Parassit; 1971 Mar; 23(3):153-4. PubMed ID: 5110261
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of blood proteins and glycoproteins in the course of meningococcic disease in childhood (sepsis and meningitis) (cellulose acetate gel radial electrophoresis)].
    Moggi C; Giovannucci ML; Calabri G; Berti S
    Riv Clin Pediatr; 1969; 82():412-6. PubMed ID: 5405496
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children.
    Joseph H; Ryall R; Bybel M; Papa T; MacLennan J; Buttery J; Borrow R
    J Infect Dis; 2003 Apr; 187(7):1142-6. PubMed ID: 12660929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of vaccine in meningococcal disease in Cantabria].
    González de Aledo Linos A; García Merino J
    Rev Esp Salud Publica; 1998; 72(5):415-8. PubMed ID: 9951334
    [No Abstract]   [Full Text] [Related]  

  • 5. Properdin deficiency in a family with fulminant meningococcal infections.
    Sjöholm AG; Braconier JH; Söderström C
    Clin Exp Immunol; 1982 Nov; 50(2):291-7. PubMed ID: 7151327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy with heparin in meningococcic sepsis].
    Masera G; Carnelli V
    Minerva Pediatr; 1969 Mar; 21(10):394-401. PubMed ID: 5777642
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA histocompatibility antigens and meningococcal disease.
    Kristiansen BE; Thorsby E
    NIPH Ann; 1980 Dec; 3(2):75-9. PubMed ID: 7219842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methodology of the study of pre- and post-vaccination antibodies against serogroup C Meningococcus].
    Espín Ríos I; García Fulgueiras A; Vázquez Moreno J; Navarro Sánchez C; Rodríguez González T; Navarro Alonso JA; Pérez Flores D
    Rev Esp Salud Publica; 1998; 72(5):419-22. PubMed ID: 9951335
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the campaign on vaccination against meningococcal disease in Galicia. Methodology, advantages and disadvantages, Study of carriers].
    Malvar Pintos A
    Rev Esp Salud Publica; 1998; 72(5):393-400. PubMed ID: 9951330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Meningococcic disease. Some brief considerations on diagnosis and therapy, with special reference to the more serious forms of sepsis].
    Garofalo P; Martini Mauri M
    G Mal Infett Parassit; 1968 May; 20(5):452-4. PubMed ID: 5744464
    [No Abstract]   [Full Text] [Related]  

  • 11. [Were the meningococcal vaccination campaigns in 1974-76 of benefit?].
    Peltola H; Nors T; Salminen S; Käyhty H; Sivonen A; Jousimies-Somer H; Mäkelä P
    Duodecim; 1983; 99(5):332-41. PubMed ID: 6872895
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of the massive campaign for immunization against Meningococcus (serogroup C) in the Autonomic Community of the Basque Province].
    Elexpe Uriarte X
    Rev Esp Salud Publica; 1998; 72(5):423-30. PubMed ID: 9951336
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased risk of invasive meningococcal disease, pregnancy, and confounding.
    Tozzi AE; De Benedetti F; Carsetti R
    Pediatrics; 2005 Sep; 116(3):798-9; author reply 799. PubMed ID: 16140727
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of seroconversion and duration of immunity induced by the meningococcal serogroup C vaccine. Study included in the evaluation of the mass immunization of the population in the age group between 18 months and 19 years in the community of Madrid].
    Ramírez Fernández R
    Rev Esp Salud Publica; 1998; 72(5):401-6. PubMed ID: 9951331
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cellular immunity indices in generalized forms of meningococcal infection].
    Arbekova VP
    Vopr Okhr Materin Det; 1980 Sep; 25(9):43-5. PubMed ID: 6999727
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of seroconversion of the Neisseria meningitidis serogroup C vaccine, duration of antibody levels in the Autonomic Community of Extremadura].
    Ramos Aceitero JM
    Rev Esp Salud Publica; 1998; 72(5):411-4. PubMed ID: 9951333
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease.
    Frøholm LO
    NIPH Ann; 1980 Dec; 3(2):67-74. PubMed ID: 6784045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of penicillin therapy of meningococcal infection in children undergoing different regimes of pathogenetic therapy].
    Vereshchagin IA; Kovalenko TI; Kurakina LT
    Antibiotiki; 1983 Oct; 28(10):764-7. PubMed ID: 6651266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological study of Neisseria meningitidis strains isolated from cases of meningococcal disease in Santa Catarina State, Brazil, 1987-2003.
    de Cássia Campos Bertoncini R; André Herberts R; Goulart Dário M; Roberto Merlin C; Miletti LC
    Public Health; 2007 Nov; 121(11):880-3. PubMed ID: 17573081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.